Preview Mode Links will not work in preview mode

Sep 22, 2020

Data + Perspectives: Clinical Investigators Explore the Biology Underlying the Role of PARP Inhibition in the Management of Common Cancers — Faculty Presentation 1: PARP inhibitors for newly diagnosed ovarian cancer — Dr Matulonis.

CME information and select...


Sep 22, 2020

Data + Perspectives: Clinical Investigators Explore the Biology Underlying the Role of PARP Inhibition in the Management of Common Cancers — Faculty Presentation 2: PARP inhibitors for breast cancer — Dr Rugo.

CME information and select...


Sep 22, 2020

Data + Perspectives: Clinical Investigators Explore the Biology Underlying the Role of PARP Inhibition in the Management of Common Cancers — Faculty Presentation 3: PARP inhibitors in pancreatic cancer — Dr Philip.

CME information and select...


Sep 22, 2020

Data + Perspectives: Clinical Investigators Explore the Biology Underlying the Role of PARP Inhibition in the Management of Common Cancers — Faculty Presentation 4: PARP inhibitors in prostate cancer — Dr Hussain.

CME information and select...


Sep 21, 2020

Striving for Consensus on the Optimal Management of Metastatic Non-Small Cell Lung Cancer — Faculty Presentation 1: Biomarker assessment in metastatic NSCLC: Predictors of response to targeted therapy and immunotherapy — Dr Govindan. CME information and select publications